TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
ADMA

ADMA Biologics Inc

Healthcare · Biotechnology

9.40$ -1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

ADMA Biologics Inc (ADMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 684 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADMA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
349 329 351 376 391 489 511 558 569 624 665 684
274 257 276 304 318 331 352 400 403 467 511 528
74 51 45 88 87 103 72 90 61 88 138 136
74 51 45 88 87 103 72 90 61 88 138 136
31 27 50 30 50 50 99 110 138 158 136 138
163 173 178 180 172 170 172 191 197 206 222 239
3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5
0.5 0.5 0.3 0.5 0.5 0.5 0.5 0.5 0.5 0.6 0.6 0.6
198 194 197 188 159 140 137 160 138 147 275 276
42 50 53 44 45 56 53 75 56 70 74 76
1.0 1.0 1.1 1.1 1.2 1.2 1.2 1.1 3.6 3.9 4.5 4.9
11 16 17 14 16 20 21 30 24 23 21 32
142 131 131 131 101 72 73 73 70 69 194 193
151 135 154 188 232 349 373 398 431 477 390 408
-489 -506 -488 -456 -420 -309 -282 -247 -211 -162 -116 -79
234 226 236 242 245 246 245 249 245 244 240 230

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?